DEA Scheduling Updates: What ASCs Need to Know

How DEA Scheduling Works

The Drug Enforcement Administration (DEA) classifies controlled substances into five schedules (I through V) based on their accepted medical use, potential for abuse, and potential for dependence. These classifications directly affect how ASCs must order, store, document, and dispose of these medications.

Scheduling decisions are made through a formal rulemaking process that involves DEA, the Department of Health and Human Services (HHS), and the Food and Drug Administration (FDA). Changes can originate from DEA, HHS, Congress, or international treaty obligations.

What Happens When a Drug Is Scheduled

When a previously unscheduled medication is placed into a controlled substance schedule, ASCs must:

Immediate Requirements

• Update inventory: Add the newly scheduled medication to your controlled substance inventory. Conduct an initial count as of the effective date of the scheduling action.
• Secure storage: Move the medication to the controlled substance storage area with appropriate security measures.
• Begin perpetual inventory tracking: Start documenting all transactions (receipt, administration, waste) in your perpetual inventory system.
• Update ordering procedures: If the medication is placed in Schedule II, future orders must use DEA Form 222 or CSOS.
• Verify DEA registration: Confirm your DEA registration covers the schedule in which the medication is now classified.

Administrative Requirements

• Update pharmacy policies and procedures to include the new controlled substance
• Train staff on the changed handling requirements
• Notify your consultant pharmacist
• Update your formulary documentation

What Happens When a Drug Is Rescheduled

Rescheduling occurs when a medication is moved from one schedule to another. The direction of the move determines the impact:

Upscheduling (e.g., Schedule IV to Schedule III)

Moving to a more restrictive schedule means:

• More stringent record-keeping requirements may apply
• Storage security requirements may increase
• Ordering procedures may change (particularly if moved to Schedule II)
• Audit and monitoring frequency may need to increase

Downscheduling (e.g., Schedule II to Schedule III)

Moving to a less restrictive schedule may simplify:

• Ordering procedures (no longer requiring DEA Form 222 if moved out of Schedule II)
• Some documentation requirements may be relaxed (though best practice is to maintain rigorous tracking regardless of schedule)
• Storage requirements may be somewhat less stringent

In either case, ASCs should not assume the change is automatic. Review the specific requirements for the new schedule and update procedures accordingly.

What Happens When a Drug Is Descheduled

Descheduling removes a medication from controlled substance classification entirely. When this occurs:

• The medication no longer requires controlled substance storage or documentation
• It can be removed from perpetual inventory tracking
• Standard medication management procedures apply
• Order procedures revert to standard purchase orders
• However, some state laws may maintain scheduling even after federal descheduling. Always check Texas state law through TSBP before changing your procedures.

Recent and Notable Scheduling Actions

DEA scheduling actions that have affected or may affect ASC operations in recent years include changes to various substances used in surgical and procedural settings. ASCs should monitor the Federal Register for:

• New scheduling proposals that affect medications on their formulary
• Temporary scheduling actions (DEA can temporarily schedule substances for up to two years while permanent scheduling is evaluated)
• State-level scheduling that may differ from federal classification

How to Respond to Scheduling Changes

Step 1: Identify Affected Medications

When a scheduling change is announced:

• Review your formulary for the affected medication
• Determine current inventory quantities
• Identify who administers the medication and how frequently

Step 2: Determine the Effective Date

• Scheduling changes have specific effective dates published in the Federal Register
• Do not implement changes before the effective date
• Be prepared to comply on the effective date, not after

Step 3: Update Procedures

• Modify storage, documentation, and ordering procedures to match the new schedule
• Update perpetual inventory systems
• Revise pharmacy P&Ps
• Update staff training materials

Step 4: Communicate

• Notify all staff who handle the affected medication
• Inform your consultant pharmacist
• Update your medical director and facility administrator
• If the change affects a frequently used medication, conduct a focused training session

Step 5: Document

• Record the date you became aware of the change
• Document all procedural updates made
• Maintain evidence of staff communication and training
• Include the change in your next consultant pharmacist visit report

Monitoring Scheduling Changes

Stay informed through:

• Federal Register: The official source for all scheduling actions. Subscribe to notifications for DEA rulemaking.
• DEA Diversion Control Division: Publishes final orders and notices of scheduling actions
• Professional organizations: Pharmacy associations often provide timely alerts and summaries
• Consultant pharmacist: Should proactively communicate scheduling changes that affect your facility
• Drug wholesaler notifications: Distributors may provide alerts when scheduling changes affect products they supply

Failing to implement a scheduling change on time is a compliance violation. Proactive monitoring ensures your facility is always prepared.